Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Taichirou Nishikawa"'
Autor:
Eiichi Konishi, Toshiaki Nakashima, Masayasu Jo, Taichirou Nishikawa, Junko Yamaoka, Toshikazu Yoshikawa, Akiko Shibuya, Yoshihisa Okada, Yoshihito Itoh, Tomoki Nakajima
Publikováno v:
Pathology International. 61:572-576
We previously reported that hepatocellular aging can be assessed by measuring the nuclear size of hepatocytes. We attempted to elucidate whether this method is useful to identify the high risk group of hepatocellular carcinoma (HCC) in the patients w
Autor:
Yoshito Itoh, Keizo Kagawa, Hiroyuki Kimura, Tomoki Nakajima, Satoru Sekoguchi, Taichirou Nishikawa, Masahito Minami, Hidetaka Takashima, Takeshi Okanoue, Tatsuo Katagishi, Michihisa Moriguchi, Yoichi Tani
Publikováno v:
Liver International. 26:23-31
Aims: The risk factors associated with poor prognosis of nonalcoholic fatty liver disease (NAFLD) are not fully understood. Our aim was to assess the role of progressive hepatocellular telomere shortening in the clinical course of NAFLD. Methods: We
Autor:
Tomoki Nakajima, Masahito Minami, Hiroyuki Kimura, Keizo Kagawa, Takeshi Okanoue, Tadashi Watanabe, Satoru Sekoguchi, Taichirou Nishikawa, Yoshito Itoh, Hidetaka Takashima, Tatsuo Katagishi, Michihisa Moriguchi
Publikováno v:
Biochemical and Biophysical Research Communications. 325:1131-1135
Using quantitative fluorescence in situ hybridization (Q-FISH), the average telomere length of hepatoma cells was assessed by the average telomeric signal intensity of cancer cells relative to that of stromal cells. We demonstrated first the applicab
Autor:
Tomoki, Nakajima, Toshiaki, Nakashima, Junko, Yamaoka, Akiko, Shibuya, Eiichi, Konishi, Yoshihisa, Okada, Masayasu, Jo, Taichirou, Nishikawa, Yoshihito, Itoh, Toshikazu, Yoshikawa
Publikováno v:
Pathology international. 61(10)
We previously reported that hepatocellular aging can be assessed by measuring the nuclear size of hepatocytes. We attempted to elucidate whether this method is useful to identify the high risk group of hepatocellular carcinoma (HCC) in the patients w
Autor:
Tomoki, Nakajima, Michihisa, Moriguchi, Tatsuo, Katagishi, Satoru, Sekoguchi, Taichirou, Nishikawa, Hidetaka, Takashima, Hiroyuki, Kimura, Masahito, Minami, Yoshito, Itoh, Keizo, Kagawa, Yoichi, Tani, Takeshi, Okanoue
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 26(1)
The risk factors associated with poor prognosis of nonalcoholic fatty liver disease (NAFLD) are not fully understood. Our aim was to assess the role of progressive hepatocellular telomere shortening in the clinical course of NAFLD.We measured average
Autor:
Masahito Minami, Keizo Kagawa, Yoshito Itoh, Michiaki Ishii, Takeshi Okanoue, Masayasu Jo, Toshikazu Nakajima, Satoru Sekoguchi, Taichirou Nishikawa, Hiroyuki Kimura, Michihisa Moriguchi, Tatsuo Katagishi, Hidetaka Takashima
Publikováno v:
Journal of hepatology. 44(6)
Background/Aims A major polyphenol of green tea, epigallocatechin-3-gallate (EGCG), has previously been shown to induce cell-cycle arrest and apoptosis in various cancers. However, little is known about its effects on hepatocellular carcinomas (HCCs)
Autor:
Hidetaka Takashima, Keizo Kagawa, Michihisa Moriguchi, Yasuhide Mitsumoto, Tomoki Nakajima, Tatsuo Katagishi, Tadashi Watanabe, Hiroyuki Kimura, Satoru Sekoguchi, Taichirou Nishikawa, Takeshi Okanoue
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 17(6)
Centrosome duplication is controlled in a cell cycle-specific manner and occurs once every cell cycle, thereby ensuring the balanced segregation of chromosomes during the mitotic phase. Numerical or structural abnormalities can arise in the centrosom
Autor:
Hiroo Nakajima, Takeshi Mazaki, Akio Yanagisawa, Takeshi Okanoue, Hidetaka Takashima, Naruhiko Mizuta, Tomoki Nakajima, Yoshito Itoh, Masahito Minami, Satoru Sekoguchi, Taichirou Nishikawa, Tadashi Watanabe
Publikováno v:
World Journal of Gastroenterology. 11:2360
Hepar lobatum carcinomatosum (HLC) is defined as an acquired hepatic deformity consisting of an irregularly lobulated hepatic contour caused by intravascular infiltration of metastatic carcinoma. To date, only nine cases of HLC have been reported in